Poglady na funkcje metaboliczne karnityny po stu latach od jej odkrycia

• Autorzy: Czech E , Hartleb M.

Warianty tytułu

EN

View on metabolic functions of carnitine one hundred years after its discovery

• Języki publikacji: PL

Słowa kluczowe

PL

biosynteza; karnityna; metabolizm; struktura chemiczna; suplementacja zywnosci

• Wydawca: -
• Czasopismo: Żywienie Człowieka i Metabolizm
• Rocznik: 2005
• Tom: 32
• Numer: 3
• Opis fizyczny: s.262-275,rys.,tab.,bibliogr.

Twórcy

autor

Czech E

• Slaska Akademia Medyczna, Katowice

autor

Hartleb M.

Bibliografia

• 1. Aureli T., Di-Cocco M-E., Capuani G., et al.: Effect of long-term feeding with acetyl-L-carnitine on the age-related changes in rat brain lipid composition: a study by 31P NMR spectroscopy. Neurochem. Res., 2000, 25, 395.
• 2. Bohan T. P., Helton E., McDonald I., et al.: Effect of carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001, 56, 1405.
• 3. Böhles H.: Inborn errors of L-carnitine metabolism. Ann. Nutr. Metab., 2000, 44, 91.
• 4. Bonnefont J.P., Demaugre E, Prip-Buus C., jet al.: Carnitine palmitoyltransferase deficiencies. Mol. Genet. Metab., 1999, 68, 424.
• 5. Bonnefont J.P, Djouadi F., Prip-Buss C., et al.: Carnitine palmitoyltransferase 1 and 2: biochemical, molecular and medical aspects. Mol. Asp. Med., 2004, 25, 495.
• 6. Brass E.P.: Supplemental carnitine and exercise. J. Am. Clin. Nutr., 2000, 72 (Suppl.), 618S.
• 7. Bremer J.: The biochemistry of hypo- and hyper- lipidemic fatty acid derivatives: metabolism and metabolic effects. Prog. Lipid Res., 2001, 40, 231.
• 8. Cha Y-S., Choi S-K., Suh H., et al.: Effect of carnitine coingested caffeine on carnitine metabolism and endurance capacity in athletes. J. Nutr. Sei. Vitaminol., 2001, 47, 378.
• 9. Chien D., Dean D., Saha A., et al.: Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo. Am. J. Physiol. Endocrinol. Metab., 2000, 279, E259.
• 10. Davis A.: Fractional contributions to total carnitine in the neonatal rat. J. Nutr., 1989, 119, 262.
• 11. Di Giacomo C., Latteri F., Fichera C., et al.: Effect of acetyl-L-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem. Res., 1993, 18, 1157.
• 12. Feng Y., Guo G, Wei J., et al.: Necessity of carnitine supplementation in semistarved rats fed a high-fat diet. Nutrition, 2001, 17, 628.
• 13. Foster D.: The role of the carnitine system in human metabolism. Ann. N. Y. Acad. Sei., 2004, 1033, 1.
• 14. Furuno T., Kanno T., Arita K., et al.: Roles of long chain fatty acids and carnitine in mitochondrial membrane permeability transition. Biochem. Pharmacol., 2001, 62, 1037.
• 15. Galland S., Le Borgne F., Bouchard F., et al.: Molecular cloning and characterization of the cDNA encoding the rat liver gamma- butyrobetaine hydroxylase. Biochim. Biophys. Acta 1999, 1441, 85.
• 16. Gazola V, Lopez G., Dias R., et al.: Comparative effects of diet supplementation with 1-car- nitine and dl-carnitine on ammonia toxicity and hepatic metabolism in rats. Acta Pharmacol. Sin., 2001, 22, 305.
• 17. Ghyczy M., Boros M.: Electrophilic methyl groups present in the diet ameliorate pathological states by reductive and oxidative stress: a hypothesis. Brit. J. Nutr., 2001, 85, 409.
• 18. Goodman D., Hoekstra S., Busch R., et al.: Effects of prolactin and growth hormone on tissue and serum carnitine in the rat. Endocrinology, 1988, 123, 1955.
• 19. Guertl B., Noehammer C., Hoefler G.: Metabolic cardiomyopathies. Int. J. Exp. Pathol., 2000, 81, 349.
• 20. Guzman M., Velasco G., Geelen M.: Do cytoskeletal components control fatty acid translocation into liver mitochondria? Trends Endocrinol. Metab., 2000, 11, 49.
• 21. Hagen T., Ingersoll R., Wehr C., et al.: Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc. Nat. Acad. Sei., 1998, 95, 9562.
• 22. Hagen T., Liu J., Lykkesfeldt J., et al.: Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc. Nat. Acad. Sei., 2002, 99, 1870.
• 23. Higashi Y., Yokogawa K., Takeuchi N., et al.: Effect of a-butyrobetaine on fatty liver in juvenile visceral steatosis mice. J. Pharmac. Pharmacol., 2001, 53, 527.
• 24. Hong Y., Kim S., Yoon H-R.: Serum lipid and fatty acid profiles in adriamycin-treated rats after administration of L-carnitine. Pediatr. Res., 2002, 51, 249.
• 25. Hoppel C.: The physiological role of carnitine, w: L-carnitine and its role in medicine: from function to therapy, Ed: R. Ferrari, New York, Academic Press, 1992, 5.
• 26. Karlic H., Lohinger A.: Supplementation of L-carnitine in athletes: does it make sense? Nutrition, 2004, 20, 709.
• 27. Karlic H., Lohinger S., Koeck T., et al.: Dietary L-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J. Histochem. Cytochem., 2002, 50, 202.
• 28. Kennedy S., Stanley W., Panchal A., et al.: Alterations in enzymes involved in fat metabolism after acute and chronic altitude exposure. J. Appl. Physiol., 2001, 90, 17.
• 29. Kondrup J., Lazarow P: Flux of palmitate through the peroxisomal and mitochondrial beta-oxidation systems in isolated rat hepatocytes. Biochim. Biophys. Acta, 1985, 835, 147.
• 30. Krähenbühl S.: L-carnitine and vegetarianism. Ann. Nutr. Metab., 2000, 44, 81.
• 31. Kushnareva Y., Sokolove M.: Prooxidants open both the mitochondrial permeability transition pore and a low-conductante channel in the inner mitochondrial membrane. Arch. Biochem. Biophys., 2000, 376, 377.
• 32. Lahjouji K., Mitchell G., Quereshi I.: Carnitine transport by organic cation transporters and systemic carnitine deficiency. Molec. Genet. Metab., 2001, 73, 287.
• 33. Lesnefsky E., Moghaddas S, Tandler B., et al.: Mitochondrial dysfunction in cardiac disease: ischemia-reper- fusion, aging, and heart failure. J. Mol. Cell. Cardiol., 2001, 33, 1065.
• 34. Liu J., Head E., Gharib A., et al.: Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-car- nitine and/or R-a-lipoic acid. Proc. Nat. Acad. Sei., 2002, 99, 2356.
• 35. Liu J., Kil- lilea D., Ames B.: Age-associated mitochondrial oxidative decay: Improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R-a-lipoic acid. Proc. Nat. Acad. Sei., 2002, 99, 1876.
• 36. Lohringer A., Kriegisteiner H., Hajos F., et al.: Effects of prenatal treatment with betamethasone, L-carnitine, or betamethasone-L-carnitine combinations on the phosphatidylcholine content and composition of foetal and maternal rat lung. Eur. J. Clin. Biochem., 1996, 34,387.
• 37. Löster H.: Effects of L-carnitine on the heart. Ann. Nutr. Metab., 2000, 44, 82.
• 38. Mollica M., Iossa S., Soboli S., et al.: Acetyl-L-carnitine treatment stimulates oxygen consumption and biosynthetic function in perfused liver of young and old rats. Cell. Mol. Life Sei., 2001, 58, 477.
• 39. Murata M., Sano Y., Ishihara K, et al.: Dietary fish oil and Undaria pinnatifida (Wakame) synergistically decrease rat serum and liver triacylglycerol. J. Nutr., 2002, 132, 742.
• 40. Nakanishi T., Hatanaka T., Huang W., et al.: Na+-and Cl -coupled active transport of carnitine by the aminoacid transporter ATBO, from mouse colon expressed in HRPE cells and xenopus oocytes. J. Physiol., 2001, 532 (Pt 2), 297.
• 41. Navder KR, Baraona E., Lieber C.S.: Polyenylphosphatidylcholine attenuates alcohol-induced fatty liver and hyperlipemia in rats. J. Nutr., 1997, 127, 1800.
• 42. Neuvonen P, van der Berg A.: Postoperative coma in child with carnitine palmitoyltransferase I deficiency. Anesth. Analg., 2001, 92, 646.
• 43. Ohashi R., Tamai I., Nezu J., et al.: Molecular and physiological evidence for multifunctionality of carnitine/or- ganic cation transporter OCTN2. Mol. Pharmacol., 2001, 59, 358.
• 44. Opalka J., Gellerich F, Zierz S.: Age and sex dependency of carnitine concentration in human serum and skeletal muscle. Clin. Chem., 2001, 47, 2150.
• 45. Pastorino J., Snyder J., Serroni A., et al.: Cyclosporin and carnitine prevent the anoxic death of cultured he- patocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem., 1993, 268, 13791.
• 46. Paulson D.: Carnitine deficiency - induced cardiomyopathy. Mol. Cell. Biochem., 1998, 180, 33
• 47. Poirier L.: Methyl group deficiency in hepa- tocarcinogenesis. Drug Metab. Rev., 1994, 26, 185.
• 48. Price N. T., van der Leij F., Jackson V, et al.: A novel brain-expressed protein related to carnitine palmitoyltransferase 1. Genomics, 2002, 80, 433.
• 49. Ramsay R., Gandour R., van der Leij F.: Molecular enzymology of carnitine transfer and transport, Review. Biochim. Biophys. Acta 2001, 1546, 21.
• 50. Rebouche C.: Kinetics, pharmacokinetics, and regulation of L- carnitine and acetyl-L-carnitine metabolism. Ann. N.Y. Acad. Sei., 2004, 1033, 30.
• 51. Ricciolini R., Scalibastri M., Carminati P, et al.: The effect of pivalate treatment of pregnant rats on body mass and insulin levels in the adult offspring. Life Sei., 2001, 69, 1733.
• 52. Sachan D.S., Berger R.: Specifity of carnitine in attenuation of ethanol metabolism in rat. Biochem. Arch., 1993, 9, 141.
• 53. Sachan D.S., Hongu N.: Increases in VO2 max and metabolic markers of fat oxidation by caffeine, carnitine, and choline supplementation in rats. J. Nutr. Biochem., 2000, 11, 521.
• 54. Sachan D.S., ChaY. S.: Acetylcarnitine inhibits alcohol dehydrogenase. Biochem. Biophys. Res. Commun., 1994, 203, 1496.
• 55. Semeniuk J., Shalansky K., Taylor N., et al.: Evaluation of the effect of intravenous L-carnitine on quality of life in chronic hemodialysis patients. Clin. Nephrol., 2000, 543, 470.
• 56. Spagnioli A., Lucca U., Menasce G., et al.: Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology 1991, 41, 1726.
• 57. Sweeney J.D., Blair A.B., Cheves T.A., et al.: L-carnitine decreases glycolysis in liquid-stored platelets. Transfusion, 2000, 40, 1313.
• 58. Tacconi M.: Involvement of carnitine in Rey's and Reye-like syndromes. In: Carnitine today, Ed. De C. Simone, G. Famularo, 1997, 187.
• 59. Tran T., Christophersen B.: Studies on the transport of acetyl groups from peroxisomes to mitochondria in isolated liver cells oxidizing the polyunsaturated fatty acid 22:4n- 6. Biochim. Biophys. Acta, 2001, 1533, 255.
• 60. Ulrich R., Bacon J., Brass E., et al.: Metabolic, idiosyncratic toxicity of drugs: overview of the hepatic toxicity induced by the anxiolytic, panadiplon. Chem. Biol. Interact., 2001, 134, 251.
• 61. Vaz F., Wanders J.: Carnitine biosynthesis in mammals. Biochem. J., 2002, 361, 417.
• 62. Vesela E., Racek J., Trefil L., et al.: Effect of L-carnitine supplementation in hemodialysis patients. Nephron, 2001, 88, 218.
• 63. Vossler D., Wilensky A., Cawthon D., et al.: Serum and CSF glutaminę levels in valproate-related hyperammonemic encephalopathy. Epilepsia 2002, 43, 154.
• 64. Wächter S., Vogt M., Kreis R., et al.: Long-term administration of L-carnitine to humans: effect on skeletal muscle carnitine content and physical performance. Clin. Chim. Acta 2002, 318, 51
• 65. Yu X., Odle J., Drackley J.: Differential induction of peroxisomal ß-oxidation enzymes by clofibric acid and aspirin in piglet tissues. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2001, 281, R1553.